Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma

Breast Cancer Research and Treatment

Volumn 124, Issue 3, 2010, Pages 677-688

  Liu, Fangfang ^a   Cui, Lifang ^a   Zhang, Yang ^b   Chen, Ling ^a   Wang, Yahong ^a   Fan, Yu ^a   Lei, Ting ^a   Gu, Feng ^a   Lang, Ronggang ^a   Pringle, Gordon A ^c   Zhang, Xinmin ^c   Chen, Zhinan ^a,b   Fu, Li ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Breast carcinoma; HAb18G; Immunohistochemistry; Prognosis; Tumor progression

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HEPATOMA ASSOCIATE ANTIGEN 18G; MEMBRANE PROTEIN; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST HYPERPLASIA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDULLARY CARCINOMA; MUCINOUS CARCINOMA; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD147; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHI-SQUARE DISTRIBUTION; CHINA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 78649327037     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0790-6     Document Type: Article

References (24)

1. ZN Chen YF Liu 1990 Monoclonal antibody HAb18 to human hepatoma Monoclon Antib 8 11
2. JL Jiang Q Zhou MK Yu LS Ho ZN Chen HC Chan 2001 The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells J Biol Chem 276 50 46870 46877 1:STN:280: DC%2BD3MjgtFCmuw%3D%3D 10.1074/jbc.M108291200 11591720
3. Chen ZN, Shang P, Li Y, Qian AR, Zhu P, Xing JL, inventors (2002) NTD patent & trademark agency Ltd., Beijing office, assignee. HAb18G/CD147, its agonist and application. Chinese patent ZL01131735.3, 2001 Sep 28; PCT international patent WO02/094875, 27 May 2002
4. Y Huang J Jiang K Dou Z Chen 2005 HAb18G/CD147 enhances the secretion of matrix metalloproteinases (MMP) via cGMP/NO-sensitive capacitative calcium entry (CCE) and accordingly attenuates adhesion ability of fibroblasts Eur J Cell Biol 84 1 59 73 1:CAS:528:DC%2BD2MXislegsb4%3D 10.1016/j.ejcb.2004.09.003 15724816
5. Y Li P Shang AR Qian L Wang Y Yang ZN Chen 2003 Inhibitory effects of antisense RNA of HAb18G/CD147 on invasion of hepatocellular carcinoma cells in vitro World J Gastroenterol 9 10 2174 2177 1:CAS:528:DC%2BD3sXpsVOjsbo%3D 14562372
6. FQ Wang J So S Reierstad DA Fishman 2006 Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases Int J Cancer 118 4 879 888 1:CAS:528:DC%2BD28Xhtlaisrk%3D 10.1002/ijc.21421 16152587 (Pubitemid 43157663)
7. JL Jiang HC Chan Q Zhou MK Yu XY Yao SY Lam H Zhu LS Ho KM Leung ZN Chen 2004 HAb18G/CD147-mediated calcium mobilization and hepatoma metastasis require both C-terminal and N-terminal domains Cell Mol Life Sci 61 16 2083 2091 1:CAS:528:DC%2BD2cXotVyjsbo%3D 10.1007/s00018-004-4146-4 15316657
8. Q Zhang X Chen J Zhou L Zhang Q Zhao G Chen J Xu F Qian Z Chen 2006 CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients Cancer Biol Ther 5 7 808 814 1:CAS:528:DC%2BD28XhtVOju7%2FE 10.1158/1535-7163.MCT-06-0109 16775432 (Pubitemid 44323241)
9. Q Zhang J Zhou XM Ku XG Chen L Zhang J Xu GS Chen Q Li F Qian R Tian N Wen ZN Chen 2007 Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma Eur J Cancer Prev 16 3 196 202 10.1097/01.cej.0000236245.40619.c3 17415090 (Pubitemid 46597423)
10. GQ Bao Y Li QJ Ma XL He JL Xing XM Yang ZN Chen 2005 Isolating human antibody against human hepatocellular carcinoma by guided-selection Cancer Biol Ther 4 12 1374 1380 1:CAS:528:DC%2BD28XkvVOhu7Y%3D 10.4161/cbt.4.12.2273 16319526
11. ZN Chen L Mi J Xu, et al. 2006 Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials Int J Radiat Oncol Biol Phys 65 2 435 444 1:CAS:528: DC%2BD28XksVCktLc%3D 16690431
12. J Xu ZY Shen XG Chen, et al. 2007 A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation Hepatology 45 2 269 276 1:CAS:528:DC%2BD2sXisVKgu74%3D 10.1002/hep.21465 17256759 (Pubitemid 46374583)
13. HC Zheng H Takahashi Y Murai ZG Cui K Nomoto S Miwa K Tsuneyama Y Takano 2006 Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis Br J Cancer 95 10 1371 1378 1:CAS:528:DC%2BD28XhtF2ns77L 10.1038/sj.bjc.6603425 17088917 (Pubitemid 44760088)
14. WD Zhong ZD Han HC He XC Bi QS Dai G Zhu YK Ye YX Liang WJ Qin Z Zhang GH Zeng ZN Chen 2008 CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer Oncology 75 3-4 230 236 1:CAS:528:DC%2BD1cXhsVKju7zE 10.1159/000163852 18852494
15. W Sienel B Polzer K Elshawi M Lindner A Morresi-Hauf C Vay F Eder B Passlick CA Klein 2008 Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9 Mod Pathol 21 9 1130 1138 1:CAS:528:DC%2BD1cXhtVagsb%2FM 10.1038/modpathol.2008.102 18567995
16. S Riethdorf N Reimers V Assmann JW Kornfeld L Terracciano G Sauter K Pantel 2006 High incidence of EMMPRIN expression in human tumors Int J Cancer 119 8 1800 1810 1:CAS:528:DC%2BD28Xps1Sns7s%3D 10.1002/ijc.22062 16721788 (Pubitemid 44356836)
17. Y Li J Xu L Chen, et al. 2009 HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection Histopathology 54 6 677 687 1:CAS:528:DC%2BD1MXhvVOhsb4%3D 10.1111/j.1365-2559.2009.03280.x 19438743
18. LM McShane, et al. 2005 Reporting recommendations for tumor marker prognostic studies J Clin Oncol 23 36 9067 9072 10.1200/JCO.2004.01.0454 16172462
19. J Zhao H Liu M Wang L Gu X Guo F Gu L Fu 2009 Characteristics and prognosis for molecular breast cancer subtypes in Chinese women J Surg Oncol 100 2 89 94 10.1002/jso.21307 19544363
20. AC Wolff ME Hammond JN Schwartz, et al. 2007 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 1 118 145 1:CAS:528:DC%2BD2sXht1ejs7Y%3D 10.1200/JCO.2006.09.2775 17159189 (Pubitemid 350003059)
21. H Guo R Li S Zucker BP Toole 2000 EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface Cancer Res 60 4 888 891 1:CAS:528:DC%2BD3cXhs1Shsr8%3D 10706100
22. T Kanekura X Chen T Kanzaki 2002 Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts Int J Cancer 99 4 520 528 1:CAS:528: DC%2BD38XjsFansL4%3D 10.1002/ijc.10390 11992541 (Pubitemid 34461604)
23. J Xu HY Xu Q Zhang, et al. 2007 HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma Mol Cancer Res 5 6 605 614 1:CAS:528:DC%2BD2sXmsF2nsLY%3D 10.1158/1541-7786.MCR-06-0286 17579119 (Pubitemid 46985049)
24. Tavassoli FA, Devilee P (2003) WHO classification of tumours. Pathology & genetics tumours of the breast and female genital organs. Lyon, IARC Press, pp 28-29